Larsmont-FA Tablet SR
Images are for reference. Actual packaging may vary.
1 units • Other
Larsmont-FA Tablet SR
Montelukast (10mg) + Fexofenadine (120mg) + Acebrophylline (200mg)
₹209.00
1 units • Other
1
Delivery
Safe & Secure
Easy Returns
24/7 Support
SMARTER CARE
A little guidance.
A better choice.
Haven’t found an alternative? A health advisor can help you understand what to do next.
No matching alternative found
We haven't found a cheaper matching alternative in our catalogue right now. Our health advisors can help you explore other options.
Active composition
Fexofenadine 120 mg
+2 more active ingredients
How It Works
Fexofenadine selectively antagonizes H1 histamine receptors, inhibiting the effects of histamine in allergic reactions.
Acebrophylline enhances mucociliary clearance by reducing mucus viscosity and promoting airway relaxation.
Montelukast selectively antagonizes leukotriene receptors, inhibiting their effects on bronchoconstriction and inflammation.
Medicine Strength
120 mg
All Active Ingredients
Fexofenadine120 mg
Acebrophylline200 mg
Montelukast10 mg
Uses & Benefits
Medical applications
Anti-inflammatoryInflammationHeadacheAllergic
Larsmont-FA Tablet SR is a sustained-release formulation combining Montelukast (10mg), Fexofenadine (120mg), and Acebrophylline (200mg), designed for the management of respiratory conditions characterized by bronchoconstriction, inflammation, and allergic reactions. Montelukast, a leukotriene receptor antagonist, effectively reduces airway inflammation and bronchospasm by inhibiting leukotriene-mediated effects.
Read full descriptionShow less
Fexofenadine, a second-generation antihistamine, provides relief from allergic symptoms such as rhinorrhea, sneezing, and nasal congestion without causing significant sedation. Acebrophylline, a bronchodilator with mucolytic and anti-inflammatory properties, facilitates airway clearance by relaxing bronchial muscles and reducing mucus viscosity. The sustained-release formulation ensures prolonged therapeutic action, improving patient compliance by reducing dosing frequency.
Larsmont-FA Tablet SR is indicated for the treatment of chronic bronchitis, asthma, allergic rhinitis, and other obstructive airway diseases where combined anti-inflammatory, bronchodilator, and antihistaminic effects are beneficial. It should be used under medical supervision, with caution in patients with hepatic or renal impairment. Common side effects may include headache, gastrointestinal disturbances, and mild dizziness.
This combination therapy offers a comprehensive approach to managing respiratory symptoms, enhancing patient quality of life through multi-modal pharmacological action.
Dosage & How to Use
Dosage information not available. Please consult your doctor or pharmacist.
Safety Advice
Important precautions
Side effects
Side-effect information is not available for this medicine. Please consult your doctor or pharmacist.
Safety Advice
Alcohol
Larsmont-FA Tablet SR may be unsafe to use during pregnancy. Although there are limited studies in humans, animal studies have shown harmful effects on the developing baby. Your doctor will weigh the benefits and any potential risks before prescribing it to you. Please consult your doctor.
High Risk
Pregnancy
Information regarding the use of Larsmont-FA Tablet SR during breastfeeding is not available. Please consult your doctor.
Medical Advice
Driving
Larsmont-FA Tablet SR should be used with caution in patients with kidney disease. Dose adjustment of Larsmont-FA Tablet SR may be needed. Please consult your doctor.
Exercise Caution
Breastfeeding
Larsmont-FA Tablet SR may decrease alertness, affect your vision or make you feel sleepy and dizzy. Do not drive if these symptoms occur.
Consult Doctor
Kidney
Larsmont-FA Tablet SR is probably safe to use in patients with liver disease. Limited data available suggests that dose adjustment of Larsmont-FA Tablet SR may not be needed in these patients. Please consult your doctor.
Regular Checkup
Customer Reviews
0 reviews for Larsmont-FA Tablet SR
